Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$4.12 USD
+0.01 (0.24%)
Updated Jul 15, 2024 10:52 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.64 |
EPS Last Quarter | -0.67 |
Last EPS Surprise | 14.10% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.57 |
Next Year | -0.78 |
EPS (TTM) | -3.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.10M | 0.15M | 0.80M | 0.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.10M | 0.15M | 0.80M | 0.80M |
Low Estimate | 0.10M | 0.15M | 0.80M | 0.80M |
Year ago Sales | 0.25M | 0.32M | 0.58M | 0.80M |
Year over Year Growth Est. | -60.00% | -53.13% | 37.22% | 0.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.64 | -0.65 | -2.57 | -0.78 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.64 | -0.65 | -2.57 | -0.78 |
High Estimate | -0.58 | -0.56 | -2.25 | -0.50 |
Low Estimate | -0.69 | -0.73 | -2.89 | -1.05 |
Year ago EPS | -0.87 | -0.86 | -3.95 | -2.57 |
Year over Year Growth Est. | 26.44% | 24.42% | 34.94% | 69.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.64 | -0.65 | -2.57 | -0.78 |
7 Days Ago | -0.64 | -0.65 | -2.57 | -0.78 |
30 Days Ago | -0.64 | -0.65 | -2.57 | -0.78 |
60 Days Ago | -0.81 | -0.83 | -2.38 | -0.96 |
90 Days Ago | -0.81 | -0.83 | -2.38 | -0.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.64 | -0.65 | -2.57 | -0.78 |
Zacks Consensus Estimate | -0.64 | -0.65 | -2.57 | -0.78 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.67 | -0.92 | -0.86 | -0.87 | NA |
Estimate | -0.78 | -0.56 | -1.08 | -1.43 | NA |
Difference | 0.11 | -0.36 | 0.22 | 0.56 | 0.13 |
Surprise | 14.10% | -64.29% | 20.37% | 39.16% | 2.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more